答：从数据来看，公司研发占比提升一方面是因为集采之后 公司整体营收下降；另一方面是公司在集采降价之后仍保持原有 的研发投入。公司研发投入处于上升阶段主要因为公司涉及产品 的品相较多，公司在创伤、脊柱、关节、运动医学这四大骨科领 域以及齿科、神经外科、微创外科等非骨科领域均有相应研发投 入。公司各产线的研发投入主要聚焦在材料、工艺及临床效果（如 缩短手术时间、减小创伤等）等方面。 5、问：公司未来几年还有什么重大的资本支出计划吗？ 证券代码：002901 证券简称：大博医疗 大博医疗科技股份有限公司投资者关系活动记录表 投资者关系活动 类别 ■特定对象调研（电话会） □分析师会议 □媒体采访 □业绩说明会 □新闻发布会 □路演活动 □现场参观 □其他 （请文字说明其他活动内容） 参与单位名称及 人员姓名 国联民生证券、汇添富基金、兴证全球基金、宏利基金、福泽源 基金、工银瑞信、国泰海通证券、国联民生证券、大成基金、红 土创新基金、泽源资产、天风证券、华能贵诚信托、中金公司、 国信证券 时间 2025 年 7 月 8 日 (周二) 下午 15:30~16:30 地点 公司会议室 上市公司接待人 员姓名 董事长：林 ...

出品｜公司研究室IPO组 文｜曲奇 近日，浙江翼菲智能科技股份有限公司（简称"翼菲科技"）正式向港交所递交招股书，计划以18C章程登陆主板。若成功上市， 翼菲科技将成为港股"轻工业全品类机器人第一股"。 过去3年，翼菲科技收入年复合增速为28.5%，但2022年末到2024年末，公司应收账款及票据从0.28亿元增长至1.38亿元，增幅为 392%，远高于收入增速。 此外，翼菲科技应收账款及票据周转天数从46天延长至120天，公司回款率明显下滑。 应收账款及票据3年增长392% 值得注意的是，2022年末到2024年末，翼菲科技的应收账款及票据分别为2810万元、5230万元及1.38亿元，应收账款及票据的增 速远高于当期收入增速。 在技术上看，翼菲科技致力于创造完全自主、全栈的具身智能机器人技术，现已建立了一个整合"脑""眼""手""足"的核心技术系 统，实现智能决策、环境感知、精确操控及自主移动。 招股书显示，翼菲科技已获得271项授权专利，包括36项发明专利，222项实用新型专利及13项设计专利。 翼菲科技的业务主要分为机器人本体业务和机器人解决方案业务。 根据招股书，2020年到2024年，中国轻工业机 ...

Core Insights - China's total import and export value of goods reached 17.94 trillion yuan in the first five months of this year, with exports growing by 7.2% to 10.67 trillion yuan [1] - The export of industrial manufacturing products amounted to 6.22 trillion yuan, reflecting a growth of 9.2%, with industrial robots seeing a remarkable increase of 55.4% [1] - The cumulative production of industrial robots in China for the first four months was 221,000 units, representing a year-on-year growth of 34.1% [1] Industry Growth - The global industrial robot market is projected to reach approximately $13.63 billion in 2024 and $18.93 billion by 2031, with a compound annual growth rate (CAGR) of 4.9% from 2025 to 2031 [2] - China's industrial robot export value increased from 1.98 billion yuan in 2017 to 8.06 billion yuan in 2024, achieving a CAGR of 22.2% over seven years [2] - Multi-joint robots are the primary exported industrial robots due to their flexibility and wide applicability in complex tasks such as assembly and welding [2] Technological and Policy Support - The rapid international expansion of China's robot industry is driven by technological innovation and policy support, with significant advancements in core technologies and industrial ecosystem development [3] - Domestic companies have successfully developed core components with independent intellectual property rights, enhancing their competitiveness in the global market [3] - The ongoing competition in the industrial robot sector is prompting companies to accelerate technological iterations and upgrade their product competitiveness [3] Corporate Actions - Companies are actively expanding their overseas markets, with over 250 inquiries related to "industrial robots" on the Shenzhen Stock Exchange's interactive platform in the past month [4] - Guangdong Tuosida Technology Co., Ltd. plans to steadily advance its overseas market expansion, gaining recognition for its industrial robots and related solutions [5] - Shenyang Siasun Robot & Automation Co., Ltd. aims to continue its overseas market layout and increase its "going out" efforts to enhance overseas revenue [5] - Nanjing Estun Automation Co., Ltd. is focusing on expanding into Europe, America, the Middle East, and Southeast Asia, targeting opportunities in the electric vehicle and lithium battery sectors [5] - Companies are encouraged to focus on technological innovation and invest in core component research, while also exploring niche markets and strengthening supply chain collaborations [5]

证券代码：871478 证券简称：巨能股份 公告编号：2025-038 宁夏巨能机器人股份有限公司 投资者关系活动记录表 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、 投资者关系活动类别 □特定对象调研 二、 投资者关系活动情况 活动时间：2025 年 5 月 27 日 15:00-16:00 活动地点：线上调研 □业绩说明会 □媒体采访 □现场参观 □新闻发布会 □分析师会议 □路演活动 √其他 （线上会议） 参会单位及人员：开源证券股份有限公司、中泰证券股份有限公司、浙商证 券股份有限公司、招银理财有限责任公司、长江证券股份有限公司、山西证券股 份有限公司、民生证券股份有限公司、联储证券股份有限公司、华鑫证券有限责 任公司、国泰海通证券、国都证券有限责任公司、财富证券有限责任公司（自营）、 易方达基金管理有限公司、西部利得基金管理有限公司、九泰基金基金管理有限 公司、汇丰晋信基金管理有限公司、国泰基金、长城财富资管、英大保险、中兴 威投资管理有限公司、泰石投资管理有限公司、尚诚资产管理有限责 ...

器械前沿科学沙龙会议——人机共生时代已来 20250519 摘要 • 国内骨科手术机器人市场处于起步阶段，竞争激烈，参与品牌近 20 个， 但装机量有限，脊柱机器人年装机量约 30 台，关节机器人十几台，创伤 机器人仅一两台，市场渗透率极低，远低于腔镜机器人。 • 骨科手术机器人采购决策流程复杂，耗时约两年，涉及设备立项、预算申 报和招标挂网等环节，终端价格通常在几百万元人民币区间，需走设备销 售流程，高端技术尚未完全纳入医保体系，面临政策支持和调整。 • 患者对骨科机器人持积极态度，但行业收费体系不成熟，脊柱手术有部分 地区建立收费标准，关节和创伤手术收费标准缺失，导致医院在使用高端 技术时面临经济压力，影响了市场渗透率。 • 骨科机器人手术费用高于传统手术，自付金额差异大，江浙一带医院收费 约 3.5 万元，其他地区收费 2 万元至几千元不等，价格是影响渗透率的重 要因素，部分地区政府出台指导性文件限制收费增长。 • 脊柱机器人终端价格约 1,100 万元，关节机器人全套约 1,200 万元，两模 块约 700-800 万元，创伤机器人通常与其他设备打包出售，进货渠道价格 通常为终端价的五折左右，价格在过 ...

2025年一季度，中国工业机器人与自动化市场展现出显著的复苏韧性。尽管面临价格竞争压力，下游需 求在汽车、半导体、锂电池等领域的拉动下逐步回暖，叠加国产厂商在核心技术与市场份额上的持续突 破，行业正迎来"量质齐升"的关键阶段。一、工业机器人：需求复苏，协作机器人成增长亮点 麦格理报告显示，2025年一季度中国工业机器人销量同比增长11.6%，结束了此前的库存去化周期，汽 车主机厂、半导体、汽车零部件等领域需求稳步提升。值得关注的是，协作机器人(cobots)延续高速增 长，一季度产量同比激增41.4%，远超传统多关节机器人(12.5%)和SCARA机器人(11.2%)，成为行业"增 长极"。市场竞争与格局变化 外资品牌份额微降，国产头部崛起：国内厂商市场份额虽从2024年的52.3%小幅降至51.4%，但头 部企业表现亮眼。埃斯顿（002747）(9.9%)、汇川技术（300124）(8.9%)跻身行业前十，分别位列 第二和第四，市占率持续提升；发那科(10.1%)仍居首位，但库卡、ABB等外资品牌通过调整价格 策略扩大份额。 下游分化显著：汽车主机厂需求同比增长45.4%，锂电池行业从2024年的-19.4 ...

投资者关系活动记录表 证券代码：300124 证券简称：汇川技术 深圳市汇川技术股份有限公司投资者关系活动记录表 编号：2025-5 | | □特定对象调研 □分析师会议 | | --- | --- | | 投资者关系活动 | □媒体采访 业绩说明会 | | | □新闻发布会 □路演活动 | | 类别 | □现场参观 | | | □其他 | | 参与单位名称及 | 总体参会人员约 770 人。 | | 人员姓名 | | | 时间 | 2025 年 4 月 29 日 15:00-17:00 | | 地点 | 进门财经平台 公司董事长、总裁朱兴明先生 | | | 董事、副总裁、董事会秘书宋君恩先生 | | 上市公司接待人 | | | 员姓名 | 独立董事黄培先生 | | | 财务总监刘迎新女士 | | | 管理层对公司 2024 年年度及 2025 年第一季度的经营情况进行 | | | 了回顾，并回复投资者问题。 | | | 1、在当前的关税环境下，公司有没有感受到整个行业受到关税 | | | 影响的压力，对未来的展望？ | | 投资者关系活动 | 回复：四月份看到了一些影响但并不大，还需要观察五月份、六 | ...

Core Viewpoint - The company,拓斯达, reported a significant decline in revenue and net profit for 2024, marking its first loss since going public, primarily due to a drastic drop in its smart energy and environmental management systems business, while its core businesses in industrial robots and CNC machine tools showed strong growth [1][4][5]. Revenue and Profit Summary - In 2024, the company achieved revenue of 2.872 billion yuan, a year-on-year decline of 36.92%, and a net profit of -245 million yuan, indicating the first loss since its establishment [1]. - The smart energy and environmental management systems business saw a revenue drop of over 50%, significantly impacting overall profitability [4][5]. Business Performance Analysis - The company's automation application systems business declined by 33.74% due to strategic contraction, while self-produced multi-joint robots experienced a revenue increase of 76.04%, with total shipments exceeding 8,000 units [3][5]. - The industrial robot segment's revenue grew by 12.50%, with a gross margin increase of 3.93 percentage points, and the electric injection molding machine orders surged by 150% [5][6]. Strategic Transformation - The company is undergoing a strategic transformation by focusing on standardized, replicable core products and reducing low-margin, highly customized project-based businesses [3][4]. - The company plans to further shrink its project-based business and adjust subsidiary equity to reduce reliance on the smart energy and environmental management systems business [6][7]. Technological Advancements - The company is committed to developing embodied intelligence and integrating IT with operational technology, aiming to create a seamless connection between the physical and digital worlds [7][8]. - The new X5 motion control platform, which integrates with AI models, has been successfully implemented in the 3C industry, enhancing efficiency by 40% [7][8]. Future Outlook - The company aims to complete a closed-loop chain of "technical breakthroughs, scene implementation, and ecological construction" over the next decade, focusing on solving manufacturing pain points through product definition based on real scenarios [8]. - The first quarter of 2025 showed a continued positive trend, with product business revenue increasing by 8.87%, driven by strong demand in emerging industries [8].

Core Viewpoint - 2024 is a critical year for the company, TuoSiDa, as it undergoes a significant transformation despite facing its first historical loss due to a substantial decline in revenue and a strategic shift towards product-focused operations [2][3][8] Group 1: Financial Performance - In 2024, TuoSiDa's revenue dropped by over 30%, resulting in the company's first-ever loss since its establishment, primarily due to a 54.22% contraction in its intelligent energy and environmental management systems business [2][3] - The company has proactively reduced low-margin, high-risk projects since late 2022, leading to a historical revenue decline in 2023 and continued reductions in 2024 [2][3] - Despite the loss, the company indicates an improvement in operational quality, suggesting a transition towards becoming a product-oriented company [2][3] Group 2: Business Structure and Strategy - TuoSiDa plans to focus on developing its core product lines, including robots, CNC machine tools, and injection molding machines, while gradually divesting from non-core businesses [3][4] - The intelligent energy and environmental management systems business saw a revenue decline of over 90% in Q1 2025, while other business segments experienced a revenue growth of over 23% [3][4] - The company’s product business now accounts for a larger share of total revenue, with a 15.62 percentage point increase in contribution and a 37.43% overall gross margin [4] Group 3: Product Performance - The industrial robot segment achieved a revenue of 27,531.64 million yuan in 2024, marking a 12.50% year-on-year growth, with a gross margin of 47.53% [4] - The injection molding machine and related equipment business generated 51,121.47 million yuan in revenue, reflecting an 18.67% increase due to various market factors [5][6] - The sales of electric injection molding machines saw a significant increase, with order volume up by approximately 150% and shipment volume up over 300% [6] Group 4: Technological Advancements - TuoSiDa is positioned as a comprehensive player in the robotics industry, integrating upstream core components, midstream industrial robots, and downstream automation systems [7] - The company has launched the new X5 robot motion control platform, which serves as a critical component in bridging the gap between embodied intelligence and robotics [7][8] - TuoSiDa is collaborating with major tech companies to enhance its capabilities in embodied intelligence, creating a closed-loop system for data-driven product evolution [7][8]